| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 08/06/2008 | CN101233884A Method for preparing bead type gynostemma pentaphylla health-care tea |
| 08/06/2008 | CN101233836A High-efficiency organic circulating agricultural production system |
| 08/06/2008 | CN100408594C Lonicera macranthoides active total saponin extract and its preparing method and use |
| 08/06/2008 | CN100408573C Pyrazole compounds useful as protein kinase inhibitors |
| 08/06/2008 | CN100408567C Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 08/06/2008 | CN100408094C Application of protease inhibitor for protecting hepatocyte function |
| 08/06/2008 | CN100408092C Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases |
| 08/06/2008 | CN100408088C Medicine for treating oral ulcer |
| 08/06/2008 | CN100408083C Chinese medicinal composition for treating calculus |
| 08/06/2008 | CN100408082C Chinese medicine for treating liver |
| 08/06/2008 | CN100408069C Quality control method of oral preparation for yin enriching kidney supplementing |
| 08/06/2008 | CN100408065C Chinese medicinal preparation for treating stomatocace and preparation method thereof |
| 08/06/2008 | CN100408063C Effervescent tablet for treating infant diarrhea and its preparing method |
| 08/06/2008 | CN100408061C Medicine for treating cholestasis and hepatic fibrosis and method for preparing the same |
| 08/06/2008 | CN100408058C Stomach-power Chinese medicine preparation and preparing method |
| 08/05/2008 | US7408050 Modified CpG oligodeoxynucleotide with improved immunoregulatory function |
| 08/05/2008 | US7407980 Therapeutic agents for treating central nervous system disorders, incotinence, sexual disorders, NASAL CONGESTION; ALPHA 1 ADRENERGIC AGONISTS; N-[4-(4,5-Dihydro-1H-imidazol-2-ylmethyl)-phenyl]-methanesulfonamide; chemical synthesis by cyclization |
| 08/05/2008 | US7407964 Stable; potent; penetrates cell membranes; effectively hinders cellular apoptosis; Antiinflammatory agents, Ischemic agents, cancer, autoimmune diseases and nervous system disorders. |
| 08/05/2008 | US7407954 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity |
| 08/05/2008 | US7407934 Controlling blood glucose concentration; amylin antagonist such as 25,28,29Pro-h-amylin, pramlintide; reducing gastric motility and delaying gastric emptying |
| 08/05/2008 | US7407669 film delivers at least one oral care agent, such as antimicrobial agents and salivary stimulants |
| 08/05/2008 | US7407663 Modified immunodeficiency virus particles |
| 08/05/2008 | CA2388470C Use of carbonylamino derivatives against cns disorders |
| 08/05/2008 | CA2353808C Agent for lowering endothelin levels |
| 08/05/2008 | CA2319015C Gastroprotected omerprazole microgranules, method for obtaining same and pharmaceutical preparations |
| 08/05/2008 | CA2281706C Methods and compositions for reducing the incidence of necrotizing enterocolitis |
| 07/31/2008 | WO2008091863A1 Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis |
| 07/31/2008 | WO2008091540A2 23-substituted bile acids as tgr5 modulators and methods of use thereof |
| 07/31/2008 | WO2008091170A1 A preparation containing sodium butyrate and the application of a preparation containing sodium butyrate |
| 07/31/2008 | WO2008090944A1 Spiro-ring compound |
| 07/31/2008 | WO2008090831A1 Enzyme composition and use thereof |
| 07/31/2008 | WO2008090826A1 Method for production of mesenchymal cell, method for production of tooth, and mesenchymal cell for formation of tooth |
| 07/31/2008 | WO2008090678A1 Novel peptide |
| 07/31/2008 | WO2008090200A2 2- piperazin-1-yl-3h-imidazo[4,5-b]pyridine derivatives |
| 07/31/2008 | WO2008069688A3 Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
| 07/31/2008 | WO2008068429A3 Composition for the prevention and/or treatment of diseases associated with tnf and/or il-12 overexpression |
| 07/31/2008 | WO2008051795A3 Preventing or reducing oxidative stress or oxidative cell injury by the administration of a water-insoluble cellulose derivative |
| 07/31/2008 | WO2008051282A3 Crystalline forms of 4-(2-fluorophenyl)-6-methyl-2-(piperazin-1-yl)thieno(2,3-d)pyrimidine |
| 07/31/2008 | WO2006138571A3 Composition and methods for treating complications associated with ingestion of a medicinal, chemical or biological substance |
| 07/31/2008 | US20080183003 Neuroprotective agents; nitrate-functional, for example 1-amino-3,5-dimethyl-7-nitrateadamantane hydrochloride |
| 07/31/2008 | US20080182983 degradation of hyaluronic acid and salt with hydrolase enzymes, to a form a mixture of tetrasaccharide, then applying the mixture to chromatography columns packed with ion exchangers and elution the tetrasaccharides; heat shock protein expression promoters, antiapoptosis, cell and tissue protectants |
| 07/31/2008 | US20080182903 Weight control; sexual disorders; stomach blotting; gastrointestinal disorders; anticholesterol agents |
| 07/31/2008 | US20080182857 Heat Shock Protein 90 inhibitors; 5-(2,4-dihydroxyphenyl)-4-(naphth-1-yl)-4H-1,2,4-triazole-3-thiol; incorrect protein folding or aggregation; hydrazonederivatives react with dimiadazole cabonyl/thiocarbonyl derivatives; hydrazines derivatives react with isocyanate or isothiocyanates; tumors, cancer |
| 07/31/2008 | US20080182832 orphan nuclear Receptor agonists; chenodeoxycholic acid, ursodeoxycholic acid or cholic acid derivatives; atherosclerosis, arteriosclerosis, dyslipidemia, hypercholesterolemia, and hypertriglyceridemia.atherosclerosis, arteriosclerosis, hypercholestremia, and hyperlipidemia |
| 07/31/2008 | US20080182829 8Beta-Hydrocarbyl-Substituted Estratrienes As Selectively Active Estrogens |
| 07/31/2008 | US20080182821 Anti-Inflammatory and/or Analgesic Composition For the Intestine Comprising Branched Maltodextrins |
| 07/31/2008 | US20080182803 extract from Cassia or Senna plants comprises rubrofusarin gentiobioside with egg white, egg membrane, milk whey, yeast/vegetable proteins, soy bean, L-cysteine, L-methionine, and vitamin C; synergistic; intracellular biosynthesis of glutathione stimulator; liver, brain, vision, or immune disorders |
| 07/31/2008 | US20080182798 Novel effectors of dipeptidyl peptidase IV |
| 07/31/2008 | US20080182785 Protracted Glp-1 Compounds |
| 07/31/2008 | US20080182319 nucleotide sequence encoding a specific binding member or antibody VH or VL domain of a specific binding member that binds human eotaxin chemoattractants (eotaxin) for modulating inflammatory response; antiinflammtory agents; antiallergens; host cell |
| 07/31/2008 | US20080182314 Neuronal serine threonine protein kinase |
| 07/31/2008 | US20080181951 Treatment of humans with colloidal silver composition |
| 07/31/2008 | US20080181903 Urodilatin; immunoglobulins; fusion proteins; pharmacokinetics |
| 07/31/2008 | US20080181869 antiproliferative, antiinflammatory agent; cytokine suppressive pro- or anti-inflammatory drug; decrease in fibroblast activation, decrease in fibroblast differentiation, decrease in collagen synthesis and deposition, or increase in matrix metalloproteinase (MMP) expression or activity |
| 07/31/2008 | CA2801869A1 Oral care implement housing an oral care agent |
| 07/31/2008 | CA2676417A1 Tgr5 modulators and methods of use thereof |
| 07/31/2008 | CA2676174A1 Method for production of mesenchymal cell, method for production of tooth, and mesenchymal cell for formation of tooth |
| 07/31/2008 | CA2674636A1 Treatment of faecal incontinence |
| 07/30/2008 | EP1950563A2 Method for screening for a substance for promoting regeneration of macrophages |
| 07/30/2008 | EP1950219A1 Novel dihydropseudoerythromycin derivatives |
| 07/30/2008 | EP1950200A1 [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-11H-indol-4-yl]oxy]acetic acid methyl ester as sPLA2 inhibitor |
| 07/30/2008 | EP1950199A1 Proline derivatives and use thereof as drugs |
| 07/30/2008 | EP1949914A1 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 07/30/2008 | EP1949901A2 Inhibition of inflammation using alpha 7 receptor-binding cholinergic agonists |
| 07/30/2008 | EP1948644A1 Tricyclo substituted amides |
| 07/30/2008 | EP1948624A2 Process for the preparation of benzo[e][1,2,4]triazepin-2-one derivatives |
| 07/30/2008 | EP1948206A2 Anti-tnf alpha producing lactic acid bacteria for the treatment of chronic enterocolitis |
| 07/30/2008 | EP1948201A1 Pharmaceutical compositions comprising polymeric binders with non-hydrolysable covalent bonds and their use in treating celiac disease |
| 07/30/2008 | EP1948160A1 Treatment of mitochondria-related diseases and improvement of age-related metabolic deficits |
| 07/30/2008 | EP1758470B1 Prebiotic preparation |
| 07/30/2008 | EP1716152B1 Fused hetrocyclic compounds and their use as metabotropic receptor antagonists for the treatment of gastrointestinal disorders |
| 07/30/2008 | EP1565547B1 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 07/30/2008 | EP1478394B1 Stabilized TNFR-Fc composition comprising arginine |
| 07/30/2008 | EP1423525B1 Recombinant mva capable of expressing structural hcv antigens |
| 07/30/2008 | EP1366078B1 Ige receptor antagonists |
| 07/30/2008 | EP1285663B1 Protective interferon-beta against reinfection after liver transplantation |
| 07/30/2008 | EP1254124B1 Dipeptide nitrile cathepsin k inhibitors |
| 07/30/2008 | EP1144600B1 Akt-3 nucleic acids, polypeptides, and uses thereof |
| 07/30/2008 | EP1054881B1 Novel sulfonamide substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 07/30/2008 | CN101233106A Thiomorpholine compound and process for preparing the same |
| 07/30/2008 | CN101232822A Composition for reducing the risc of ethanol metabolism and alcohol induced neuropathy |
| 07/30/2008 | CN101232807A Compositions having a high antiviral and antibacterial efficacy |
| 07/30/2008 | CN101230331A Use of baicalin in promoting vitro directional differentiation of mesenchymal stem cells and method thereof |
| 07/30/2008 | CN101230083A Novel glycyrrhetinic acid derivatives and preparation method thereof |
| 07/30/2008 | CN101230024A Novel water-soluble azulene derivatives and preparation method thereof |
| 07/30/2008 | CN101229377A Coordinated use method of trinosin magnesium chloride and sodium chloride injecta |
| 07/30/2008 | CN101229371A Use of anti-TNFalpha antibodies and another drug |
| 07/30/2008 | CN101229359A Chinese traditional medicine compounds for treating abdomen distending pain, gastritis, gastric ulcer and preparing method thereof |
| 07/30/2008 | CN101229347A Process of preparing granular formulation treating frosttenderless gastritis |
| 07/30/2008 | CN101229346A Capsule for hepatitis B |
| 07/30/2008 | CN101229342A Chinese traditional medicine for treating hepatitis with jaundice |
| 07/30/2008 | CN101229339A Chinese traditional medicine composite for treating stomach disease and preparing method thereof |
| 07/30/2008 | CN101229332A Microwave extract method of digestion-promoting stomachic |
| 07/30/2008 | CN101229331A Medicine for treating anorexia, limosis and preparing method thereof |
| 07/30/2008 | CN101229329A Indigestion tablet and preparing process thereof |
| 07/30/2008 | CN101229327A Medicine for treating chronic hepatitis b and preparing method thereof |
| 07/30/2008 | CN101229326A Dynamic extraction process of digestion-promoting stomachic |
| 07/30/2008 | CN101229323A Lily oral liquid and quality standard and test method of pharmaceutical preparation thereof |
| 07/30/2008 | CN101229315A Method for producing salty rhizoma anemarrhenae |
| 07/30/2008 | CN101229313A Hotspring powder medicine compounds |